Breast Cancer

In this interactive module Joyce O’Shaughnessy MD and Mohammad Jahanzeb MD review practice-changing new data in the settings of early and metastatic breast cancer.

Share

Program Content

Activities

  • JAVELIN: Avelumab in MBC
    JAVELIN Solid Tumor Trial: Avelumab in Locally Advanced or Metastatic Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 10, 2015

    Expires: December 08, 2016

  • Dual Anti-HER2 Tx in LA Breast Cancer
    NSABP FB-7: Dual HER2-Targeted Therapy in HER2+ Locally Advanced Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2015

    Expires: December 11, 2016

  • Denosumab in HR+ BC
    ABCSG-18: Effect of Adjuvant Denosumab on DFS in Postmenopausal Women With Early HR+ Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 13, 2015

    Expires: December 11, 2016

  • TH3RESA Final OS Results
    TH3RESA Final Results: T-DM1 vs Physician’s Choice for HER2+ MBC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2015

    Expires: December 12, 2016

  • PALOMA-3: Palbociclib in MBC
    Fulvestrant ± Palbociclib in ER+/HER2- Breast Cancer: An Extended Follow-up of PALOMA-3
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2015

    Expires: December 12, 2016

  • ExteNET: Neratinib in HER2+
    ExteNET: DFS With Neratinib in HER2+ BC After Adjuvant Trastuzumab
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 14, 2015

    Expires: December 12, 2016

  • Pembrolizumab in ER+/HER2- BC
    KEYNOTE-028: Pembrolizumab in PD-L1+, ER+/HER2- Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2015

    Expires: December 13, 2016

  • T-DM1 vs Trastuzumab in EBC
    WSG-ADAPT: Trastuzumab Emtansine ± ET vs Trastuzumab + ET in HER2+/HR+ Early Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2015

    Expires: December 13, 2016

  • CREATE-X: Capecitabine in HER2- EBC
    CREATE-X: Adjuvant Capecitabine in HER2-Negative Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 15, 2015

    Expires: December 13, 2016

  • Neoadjuvant Palbociclib in ER+/HER2- BC
    Neoadjuvant Palbociclib + Anastrozole in ER+/HER2- Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2015

    Expires: December 14, 2016

  • Neoadjuvant Carboplatin in Early BC
    GeparSixto: Neoadjuvant Chemotherapy ± Carboplatin in Patients With HER2-Positive or Triple-Negative Early Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2015

    Expires: December 14, 2016

  • Buparlisib in HR+/HER2- MBC
    BELLE-2: Fulvestrant ± Buparlisib in HR+/HER2- Advanced Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 16, 2015

    Expires: December 14, 2016

  • Albumin-Bound Paclitaxel Regimens in TNBC
    WSG-ADAPT TN: Neoadjuvant Albumin-Bound Paclitaxel + Carboplatin or Gemcitabine in TNBC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 17, 2015

    Expires: December 15, 2016

  • BCIRG 006: 10-Yr Follow-up
    BCIRG 006: 10-Yr Follow-up of Adjuvant AC → T Compared With AC → TH and TCH for HER2+ Early BC
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2015

    Expires: December 16, 2016

  • Abemaciclib Combinations in MBC
    Abemaciclib + Endocrine or HER2-Targeted Therapies in Metastatic Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 18, 2015

    Expires: December 16, 2016

  • Downloadable Slideset
    New Developments in Breast Cancer
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 11, 2016

    Expires: January 09, 2017

Provided by

ProCE Banner

Supporters

Genentech BioOncology

Novartis Pharmaceuticals Corporation